From: Antivirals blocking entry of enteroviruses and therapeutic potential
Peptide | Sequence | Potency (EC50 or IC50) | EV inhibited | Refs |
---|---|---|---|---|
SP40 | Ac-QMRRKVELFTYMRFD-NH2 | 6–9.3 µM | EV-A71, CV-A16, PV1 | [88] |
SP45 | Ac-AEFTFVACTPTGEVV-NH2 | N/A | EV-A71 | [88] |
SP55 | Ac-PESRESLAW-NH2 | N/A | EV-A71 | [88] |
SP81 | Ac-SKSKYPLVVRIYMRMKHVRAW-NH2 | N/A | EV-A71 | [88] |
LVLQTM | LVLQTM | nM–µM | EV-A71, Echo-6, RV-2 | |
Tripeptide VAD | VAD | µM | RV-2 | [92] |
Tetrapeptide AAPV | AAPV | µM | PV-1, CV-A21, RV-2 | [93] |